Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality‐of‐life assessments

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|17|2694-2703

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.17, 2014-09, pp. : 2694-2703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic–pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units

By Hagihara Mao   Kasai Hidefumi   Umemura Takumi   Kato Takahiro   Hasegawa Takaaki   Mikamo Hiroshige  

Journal of Infection and Chemotherapy, Vol. 17, Iss. 2, 2011-04 ,pp. : 224-230

Springer Publishing Company

Access to resources Recommend Favorite

Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 238-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer

By  

CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. : 77-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 311-314

Karger

Access to resources Recommend Favorite

Phase I and Pharmacokinetic Study of S-1 Combined with Weekly Paclitaxel in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 414-420

Karger

Access to resources Recommend Favorite